Comparative Efficacy of Drugs for Pediatric NAFLD from a Bayesian Network Meta-Analysis
19 randomized controlled trials involving 1,582 pediatric NAFLD patients form the basis of this analysis. The dataset, published by Ming-Lu Wang on figshare, compares the efficacy of drugs targeting energy, inflammation, fibrosis, and gut microbiota pathways. It includes primary outcomes on hepatic steatosis improvement and secondary outcomes on liver enzymes, lipids, and metabolic parameters.